Even though SLC38A3 exhibits functional features that are almost identical with those of SLC38A5 [7], the expression of the former is actually decreased in breast cancer, and the decrease is independent of the hormone receptor status of the tumor (TCGA database). This evidence concerns the gene SLC38A5 and breast carcinoma.